Advertisement

Acetazolamide Injection

[12 November 2014]

Products Affected - Description

Acetazolamide injection, West-Ward (formerly Bedford product)
500 mg vial (NDC 55390-0460-01)
 
Acetazolamide injection, Sagent
500 mg vial (NDC 25021-0817-10)

Reason for the Shortage

West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired acetazolamide injection from Bedford in July 2014. West-Ward is not actively marketing acetazolamide injection at this time.

Available Products

Acetazolamide injection, X-Gen Pharmaceuticals
500 mg vial (NDC 39822-0190-01)
500 mg Novaplus vial (NDC 39822-0190-07)

Estimated Resupply Dates

Sagent has acetazolamide injection available but the product has short expiration dating (February 2015). 

Related Shortages

Updated

November 12, 2014; August 27, 2014; June 5, 2014; March 17, 2014; December 17, 2013; October 14, 2013; August 13, 2013; June 11, 2013; April 29, 2013; March 7, 2013; January 22, 2013; January 14, 2013; October 30, 2012; August 22, 2012; June 20, 2012; April 11, 2012; February 7, 2012; November 21, 2011; November 8, 2011; September 16, 2011; July 22, 2011; July 1, 2011; May 26, 2011; March 11, 2011; January 25, 2011; December 14, 2010; November 8, 2010; October 19, 2010; September 14, 2010; August 17, 2010; September 23, 2008; September 16, 2008; September 9, 2008; August 28, 2008, Copyright 2014, University of Utah, Drug Information Service.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement